Table I.
Clinical characteristics of 391 patients (239 alive and 152 dead) with bladder cancer acquired from The Cancer Genome Atlas database.
| Patient status | |||
|---|---|---|---|
| Variable | Alive, n (%) | Dead, n (%) | Overall |
| Sex | |||
| Female | 58 (24.3) | 42 (27.6) | 100 (25.6) |
| Male | 181 (75.7) | 110 (72.4) | 291 (74.4) |
| Age, years | |||
| ≥65 | 131 (53.0) | 116 (47.0) | 247 (63.2) |
| <65 | 108 (75.0) | 36 (25.0) | 144 (36.8) |
| Grade | |||
| High | 216 (90.4) | 152 (100) | 368 (94.1) |
| Low | 21 (8.8) | 0 (0) | 21 (5.4) |
| Unknown | 2 (0.8) | 0 (0) | 2 (0.5) |
| Clinical Stage | |||
| I | 2 (0.8) | 0 (0) | 2 (0.5) |
| II | 98 (41.0) | 26 (17.1) | 124 (31.7) |
| III | 85 (35.6) | 47 (30.9) | 132 (33.8) |
| IV | 54 (22.6) | 78 (51.3) | 132 (33.8) |
| Unknown | 0 (0) | 1 (0.7) | 1 (0.3) |
| T stage | |||
| 0 | 1 (0.4) | 0 (0) | 1 (0.3) |
| 1 | 3 (1.3) | 0 (0) | 3 (0.8) |
| 2 | 30 (12.6) | 8 (5.3) | 38 (9.7) |
| 2a | 21 (8.8) | 2 (1.3) | 23 (5.9) |
| 2b | 35 (14.6) | 17 (11.2) | 52 (13.3) |
| 3 | 27 (11.3) | 13 (8.6) | 40 (10.2) |
| 3a | 36 (15.1) | 32 (21.1) | 68 (17.4) |
| 3b | 37 (15.5) | 41 (27.0) | 78 (19.9) |
| 4 | 5 (2.1) | 6 (3.9) | 11 (2.8) |
| 4a | 23 (9.6) | 18 (11.0) | 41 (10.5) |
| 4b | 1 (0.4) | 3 (2.0) | 4 (1.0) |
| Unknown | 20 (8.4) | 11 (7.2) | 31 (7.9) |
| X | 0 (0) | 1 (0.7) | 1 (0.3) |
| N stage | |||
| 0 | 165 (69.0) | 60 (39.5) | 225 (57.5) |
| 1 | 20 (8.4) | 24 (15.8) | 44 (11.3) |
| 2 | 29 (12.1) | 45 (29.6) | 74 (18.9) |
| 3 | 3 (1.3) | 5 (3.3) | 8 (2.0) |
| X | 19 (7.9) | 16 (10.5) | 35 (9.0) |
| Unknown | 3 (1.3) | 2 (1.3) | 5 (1.3) |
| M stage | |||
| 0 | 125 (52.3) | 59 (38.8) | 184 (47.1) |
| 1 | 4 (1.7) | 6 (3.9) | 10 (2.6) |
| X | 109 (45.6) | 86 (56.6) | 195 (49.9) |
| Unknown | 1 (0.4) | 1 (0.7) | 2 (0.5) |
T, tumor; N, node; M, metastasis; X, for the Tx, Nx or Mx stage.